North Rock Partners, LLC Vertex Pharmaceuticals Inc Transaction History
North Rock Partners, LLC
- $1.14 Billion
- Q3 2024
A detailed history of North Rock Partners, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, North Rock Partners, LLC holds 1,905 shares of VRTX stock, worth $906,741. This represents 0.08% of its overall portfolio holdings.
Number of Shares
1,905
Previous 2,264
15.86%
Holding current value
$906,741
Previous $1.06 Million
16.59%
% of portfolio
0.08%
Previous 0.09%
Shares
10 transactions
Others Institutions Holding VRTX
# of Institutions
1,717Shares Held
226MCall Options Held
1.21MPut Options Held
1.56M-
Capital World Investors Los Angeles, CA26.7MShares$12.7 Billion2.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA23MShares$10.9 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$10.1 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.7MShares$5.58 Billion0.24% of portfolio
-
Capital Research Global Investors Los Angeles, CA8.54MShares$4.06 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $122B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...